Disclosed is the novel protein "Erythroid Differentiation and Denucleation Factor" (EDDF) which is capable of inducing production of red blood cells from hematopoietic stem cells both in vitro and in vivo. Methods of stimulating hematopoietic stem cells to generate various lineages of cells are important in medicine. It will be interesting to see if the EDDF also has similarity to EPO in terms of inducing stimulation of neural stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.